Request Trial

Biotech news

Reset all filters
Geography
Company
Refine search
Explaining genetically engineered rodents to a jury—and ultimately beating Amgen
Biotech
Explaining genetically engineered rodents to a jury—and ultimately beating Amgen
Harbour’s trial counsel shares the strategy behind the company’s $20m win, revealing how a highly technical patent dispute became a case about credibility as much as science.   10 July 2026
BioNTech and Pfizer secure big European win over mRNA patent
Biotech
BioNTech and Pfizer secure big European win over mRNA patent
UPC judges revoke a patent asserted against the companies over their Comirnaty COVID-19 vaccine, in a ruling that clarified the court’s key principles on exclusive licences, novelty and inventive step.   8 July 2026
LSD trade secrets suit over clinical trail info thrown out by judge
Biotech
LSD trade secrets suit over clinical trail info thrown out by judge
A federal court has ruled in a dispute between a clinical trial technology company and a psychedelic drug developer over allegations of trade secret misuse during a bidding process.   2 July 2026
Careers
HGF expands European offering with pair of in-house hires
The firm has appointed two new partners in Basel and Bristol, adding decades of expertise from the pharmaceutical and biotech sectors to its growing life sciences practice.   2 July 2026
Regulation & Industry
Ashurst Perkins Coie opens its doors following landmark merger
The newly combined transatlantic firm brings together more than 950 partners across 20 countries, uniting leading patent, trade secrets, life sciences, and tech practices.   29 June 2026
Regulation & Industry
Merck KGaA agrees $11.3bn deal in major life sciences expansion
Deal is aimed at strengthening German company’s presence across high-growth life sciences markets by adding a portfolio of advanced research and analytical technologies.   26 June 2026
Biotech
Pfizer’s US Paxlovid patent fight turns on a single error
The Federal Circuit has brought Paxlovid’s infringement case to an end, serving as a reminder that even minor changes to patent language can have major consequences.   25 June 2026
Regulation & Industry
Novartis and Eli Lilly sign separate $1.9bn novel drug deals
Novartis will work with a US biotech company on new cancer therapies, while Lilly has partnered with a Chinese biopharma firm to develop new medicines.   25 June 2026
Regulation & Industry
GLP-1 patents and Africa: The COVID-19 lessons we still have not learned
Weight loss drugs promise a diabetes breakthrough in Africa, but patent barriers stall access. What does COVID-19 tell us about how to solve the continent’s silent crisis? Asks Sofia Araújo of Inventa.   24 June 2026
Regulation & Industry
Insilico lands potential $2.5bn AI biotech partnership
The partnership, announced at BIO 2026, marks the largest Asia-Pacific partnership by potential value that the AI-driven drug discovery company has secured to date.   22 June 2026